Company Filing History:
2 out of 4,770 
1 out of 2,405 
Years Active: 2009-2010
Title: Maricel Torrent: Innovating Cancer Treatment
Introduction
Maricel Torrent is a prominent inventor from Lansdale, PA, known for her significant contributions to the field of biomedical innovations. With a total of two patents to her name, her work focuses on developing therapies for cellular proliferative diseases, including cancer.
Latest Patents
Maricel's latest patents include groundbreaking inventions related to mitotic kinesin inhibitors. The first patent describes dihydropyrazole compounds that are effective in treating disorders associated with KSP kinesin activity, which play a significant role in cellular proliferation. These compounds not only target KSP kinesin but also offer compositions and methods for treating cancer in mammals. The second patent presents N-substituted benzylic aniline derivatives, again emphasizing their utility in combating cellular proliferative diseases and cancers linked to KSP kinesin activity. Both inventions contribute valuable insights and potential treatment options in oncology.
Career Highlights
Maricel Torrent has built an impressive career, working with renowned companies such as Merck & Company, Inc. and Merck Sharp & Dohme Corporation. Her experience in these prestigious organizations has allowed her to refine her research and development skills, leading to her innovative breakthroughs in cancer treatment.
Collaborations
Throughout her career, Maricel has collaborated with esteemed colleagues like Michael J Breslin and Paul J Coleman. Such collaborations not only foster a dynamic environment for innovation but also enhance the development of more effective treatments through shared expertise.
Conclusion
Maricel Torrent exemplifies dedication and innovation in the field of healthcare through her inventions aimed at tackling cancer and related diseases. Her patents are a testament to her work's significance and potential impact on modern medicine. As she continues her research, the scientific community and patients alike await the advancements that may stem from her pioneering efforts.